- Markets
- Healthcare
- GODAVARI
GODAVARI
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Godavari Drugs To Release Payment Of 4.9 Million Rupees For Lease Of Land
Nov 15 (Reuters) - Godavari Drugs Ltd GDRU.BO:
ACCEPTED TO RELEASE PAYMENT OF 4.9 MILLION RUPEES FOR LEASE OF LAND
Source text for Eikon: ID:nBSE4DtP2z
Further company coverage: GDRU.BO
(([email protected];))
Nov 15 (Reuters) - Godavari Drugs Ltd GDRU.BO:
ACCEPTED TO RELEASE PAYMENT OF 4.9 MILLION RUPEES FOR LEASE OF LAND
Source text for Eikon: ID:nBSE4DtP2z
Further company coverage: GDRU.BO
(([email protected];))
Events:
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Godavari Drugs do?
Godavari Drugs Ltd specializes in manufacturing and selling bulk drugs, including Pyrazinamide and Ethambutol HCL. They also offer contract manufacturing services.
Who are the competitors of Godavari Drugs?
Godavari Drugs major competitors are Ind-Swift, Vivo Bio Tech, Biofil Chem & Pharma, Rajnish Wellness, JFL Life Sciences, Vista Pharma, Makers Laboratories. Market Cap of Godavari Drugs is ₹71 Crs. While the median market cap of its peers are ₹71 Crs.
Is Godavari Drugs financially stable compared to its competitors?
Godavari Drugs seems to be less financially stable compared to its competitors. Altman Z score of Godavari Drugs is 2.27 and is ranked 4 out of its 8 competitors.
Does Godavari Drugs pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Godavari Drugs latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Godavari Drugs allocated its funds?
Companies resources are allocated to majorly unproductive assets like Capital Work in Progress
How strong is Godavari Drugs balance sheet?
Balance sheet of Godavari Drugs is moderately strong, But short term working capital might become an issue for this company.
Is the profitablity of Godavari Drugs improving?
Yes, profit is increasing. The profit of Godavari Drugs is ₹6.15 Crs for TTM, ₹5.55 Crs for Mar 2024 and ₹3.79 Crs for Mar 2023.
Is the debt of Godavari Drugs increasing or decreasing?
Yes, The debt of Godavari Drugs is increasing. Latest debt of Godavari Drugs is ₹55.85 Crs as of Sep-24. This is greater than Mar-24 when it was ₹52.52 Crs.
Is Godavari Drugs stock expensive?
Godavari Drugs is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE. Latest PE of Godavari Drugs is 11.62, while 3 year average PE is 13.32. Also latest EV/EBITDA of Godavari Drugs is 9.62 while 3yr average is 8.48.
Has the share price of Godavari Drugs grown faster than its competition?
Godavari Drugs has given lower returns compared to its competitors. Godavari Drugs has grown at ~9.89% over the last 2yrs while peers have grown at a median rate of 18.06%
Is the promoter bullish about Godavari Drugs?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Godavari Drugs is 52.63% and last quarter promoter holding is 52.63%.
Are mutual funds buying/selling Godavari Drugs?
There is Insufficient data to gauge this.